siRNA therapy lowers triglycerides in individuals with uncommon problem

.RESEARCH FEATURE.19 September 2024.

Plozasiran lessened triglyceride levels by 80% and also lowered the risk of pancreatitis in patients with chronic chylomicronemia, along with or without a hereditary prognosis.